These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 15528792)
1. Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database. Peltomäki P; Vasen H Dis Markers; 2004; 20(4-5):269-76. PubMed ID: 15528792 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939 [TBL] [Abstract][Full Text] [Related]
3. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587 [TBL] [Abstract][Full Text] [Related]
4. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Peltomäki P; Vasen HF Gastroenterology; 1997 Oct; 113(4):1146-58. PubMed ID: 9322509 [TBL] [Abstract][Full Text] [Related]
5. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Peltomäki P; de la Chapelle A Adv Cancer Res; 1997; 71():93-119. PubMed ID: 9111864 [TBL] [Abstract][Full Text] [Related]
6. Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Park JG; Kim DW; Hong CW; Nam BH; Shin YK; Hong SH; Kim IJ; Lim SB; Aronson M; Bisgaard ML; Brown GJ; Burn J; Chow E; Conrad P; Douglas F; Dunlop M; Ford J; Greenblatt MS; Heikki J; Heinimann K; Lynch EL; Macrae F; McKinnon WC; Möeslein G; Rossi BM; Rozen P; Schofield L; Vaccaro C; Vasen H; Velthuizen M; Viel A; Wijnen J; Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3389-93. PubMed ID: 16740762 [TBL] [Abstract][Full Text] [Related]
7. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
8. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
9. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
10. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
11. Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Thompson E; Meldrum CJ; Crooks R; McPhillips M; Thomas L; Spigelman AD; Scott RJ Clin Genet; 2004 Mar; 65(3):215-25. PubMed ID: 14756672 [TBL] [Abstract][Full Text] [Related]
12. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene. Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003 [TBL] [Abstract][Full Text] [Related]
13. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158 [TBL] [Abstract][Full Text] [Related]
14. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354 [TBL] [Abstract][Full Text] [Related]
15. Screening families with endometrial and colorectal cancers for germline mutations. Liu T; Chen J; Salahshor S; Kuismanen S; Holmberg E; Grönberg H; Peltomäki P; Lindblom A J Med Genet; 2001 Sep; 38(9):E29. PubMed ID: 11546830 [No Abstract] [Full Text] [Related]
16. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294 [TBL] [Abstract][Full Text] [Related]
17. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201 [TBL] [Abstract][Full Text] [Related]
18. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
20. Molecular basis of HNPCC: mutations of MMR genes. Papadopoulos N; Lindblom A Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]